English English | | | |   | |
  -
    .     .     (   ), ,    ,   .     (   )

:   , , , . ( ). : , 2012. 1. . 2. . 198-200. ISSN 1997-292X.
:
| | |

.

  ,   



. " ", , . , , -.
: , , , , , , medicinal products, pharmaceuticals, generics, quality product, patents, innovations.
PDF. PDF- .

 

:
  1. Abraham J. Science, Politics and the Pharmaceutical Industry // Medicine, Society and Industry. 1995. 2.
  2. Engelberg Alfred B. Special Patent Provisions for Pharmaceuticals: Have They Outlived their Usefulness?: a Political, Legislative and Legal History of U.S. Law and Observations for the Future // The Journal of Law and Technology. 1999. 39.
  3. Flannery Ellen J., Hutt Barton P. Balancing Competition and Patent Protection in the Drug Industry: the Drug Price Competition and Patent Term Restoration Act of 1984 // Food, Drug, Cosmetic Law Journal. 1985. 3.
  4. Glasgow Lara J. Stretching the Limits of Intellectual Property Rights: Has the Pharmaceutical Industry Gone Too Far? // The Journal of Law and Technology. 2001. 2.
  5. Hilts Philipp J. Protecting America's Health: the FDA, Business, and One Hundred Years of Regulation. New York: Knopf, 2003. 394 p.
  6. Merill R. A. The Architecture of Government Regulation of Medical Products // Virginia Law Review. 1996. Vol. 82. 8. P. 1753-1866.
  7. Roche Products Inc. v. Bolar Pharmaceutical Co. [ ]. URL: http://biotech.law.lsu.edu/cases
  8. Shanker Singham A. Competition Policy and the Stimulation of Innovation: TRIPS and the Interface between Competition and Patent Protection in the Pharmaceutical Industry // Brooklyn Journal of International Law. 2000. 26.
  9. Temin P. Taking Your Medicine: Drug Regulation in the United States. Cambridge: Harvard University Press, 1980.
  10. University of Rochester v. G. D. Searl & Co. [ ]. URL: http://www.ll.georgetown.edu/federal/judicial/ fed/opinions/03opinions/03-1304.html

| | |

2006-2017

, : krav.ru